REFERENCES
- Brown DB, Chapman WC, Cook RD, Chemoembolization of hepatocellular carcinoma: Patient status at presentation and outcome over 15 years at a single center. Am J Roentgenol. 2008;190(3):608–615.
- Fracanzani AL, Conte D, Fraquelli M, Increased cancer risk in a cohort of 230 patients with hereditary haemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology. 2001;33(3):647–651.
- Mancuso A, Sciarrino E, Penda MC, Maggio A. A prospective study of hepatocellular carcinoma incidence in thalassemia. Hemoglobin. 2006;30(1):119–124.
- Borgna-Pignatti C, Vergine G, Lombardo T, Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol. 2004;124(1):114–117.
- Bruix J, Sherman M, Llovet JM, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. J Hepatol. 2001;35(3):421–430.
- Velazquez RF, Rodriguez M, Navascues CA, Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003;37(3):520–527.
- El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36(5, Suppl. 1):574–583.
- Bruix J, Calvet X, Costa J, Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989:2(8670):1004–1006.
- Trinchet JC, Ganne-Carrie N, Nahon P, N'Kontchou G, Beaugrand M. Hepatocellular carcinoma in patients with hepatitis C virus related chronic liver disease. World J Gastroenterol. 2007;13(17):2455–2460.
- Deugnier YM, Guyader D, Crantock L. Primary liver cancer in genetic hemochromatosis: a clinical, pathological and pathogenetic study of 54 cases. Gastroenterology. 1993;104(1):228–234.
- Hann HWL, Stahlhut MW, Rubin R, Maddrey WC. Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice. Cancer. 1992;70(8):2051–2056.
- Tabor E, Kim CM. Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine. J Med Virol. 1991;34(1):45–50.
- Bacon BR, Britton RS. Hepatic injury in chronic iron overload; role of lipid peroxidation. Chem Biol Interact. 1989;70(3-4):183–226.
- Britton RS. Metal-induced hepatotoxicity. Semin Liver Dis. 1996;16(1):3–12.
- Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Rilli A, Usefulness of α-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res. 2003;23(2):1747–1753.
- Tangkijvanich P, Anukulkarnkusol W, Suwangool P, Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum α-fetoprotein levels. J Clin Gastroenterol. 2000;31(4):302–308.
- Ambu R, Crisponi G, Sciot R. Uneven hepatic iron and phosphorus distribution in β-thalassemia. J Hepatol. 1995;23(5):544–549.